Approval · Notice of Compliance 37915 · 2026
SYNCROPROST: Notice of Compliance 37915
Issued July 16, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 37915
- Date
- July 16, 2026
- Company
- Ceva Animal Health IncGuelph, Ontario, Canada
- Product type
- Veterinary
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Reason
- Addition of a new small inner label for the 20 mL vial.
- Canadian reference product
- ESTRUMATE (Intervet Canada Corp)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SYNCROPROST | 02561522 | Marketed |
Medicinal ingredients
- CLOPROSTENOL SODIUM 250 MCG per ML